Johnson & Johnson MedTech‘s Shockwave Medical today announced one-year results in a study using its Javelin peripheral IVL catheter. Yesterday, the company shared findings from a separate intravascular lithotripsy (IVL) study. It presented findings at the annual Vascular InterVentional Advances (VIVA) meeting in Las Vegas. Today, it shared … [Read more...] about J&J’s Shockwave shares data supporting Javelin forward IVL
Johnson & Johnson
J&J’s Shockwave reports positive IVL data for below-the-knee lesions, CLTI
Johnson & Johnson MedTech‘s Shockwave Medical today announced one-year results supporting the use of its Shockwave peripheral IVL system. Shockwave shared findings from DISRUPT BTK II. The post-market study evaluates the safety and effectiveness of the company's intravascular lithotripsy (IVL) system for the treatment of calcified lesions … [Read more...] about J&J’s Shockwave reports positive IVL data for below-the-knee lesions, CLTI
Johnson & Johnson MedTech launches ventricular arrhythmia ablation registry
Johnson & Johnson MedTech today introduced the Collaborative Outcomes Registry for Evidence in Ventricular Arrhythmias (CORE-VA). The company announced the registry during the International Symposium on Ventricular Arrhythmias in Philadelphia. It aims to capture contemporary practice patterns in ventricular arrhythmia (VA). That includes … [Read more...] about Johnson & Johnson MedTech launches ventricular arrhythmia ablation registry
J&J’s Shockwave launches Javelin IVL catheter in Europe
Johnson & Johnson MedTech‘s Shockwave Medical announced today that it launched its Javelin peripheral IVL catheter in Europe. The novel, non-balloon catheter comprises part of the company's first-of-its-kind forward intravascular lithotripsy (IVL) platform. It features a similar safety and effectiveness profile to legacy Shockwave IVL … [Read more...] about J&J’s Shockwave launches Javelin IVL catheter in Europe
Johnson & Johnson wins FDA nod for intravesical drug delivery tech
Johnson & Johnson (NYSE:JNJ) announced today that the FDA approved Inlexzo, its gemcitabine intravesical drug delivery system. The intravesical gemcitabine-releasing system, previously known as TAR-200, treats patients with Bacillus Calmette-Guérin (BCG)-unresponsive high-risk non-muscle invasive bladder cancer (HR-NMIBC) with carcinoma in … [Read more...] about Johnson & Johnson wins FDA nod for intravesical drug delivery tech
Johnson & Johnson MedTech reports positive Varipulse study findings
Johnson & Johnson MedTech (NYSE: JNJ) today announced positive safety and effectiveness results from a substudy of its Varipulse platform. VARIPURE, a substudy of the SECURE study, evaluated Varipulsel in pulsed field ablation (PFA) procedures for treating AFib. Investigators shared results at the 2025 European Society of Cardiology (ESC) … [Read more...] about Johnson & Johnson MedTech reports positive Varipulse study findings
Johnson & Johnson MedTech gets updated FDA nod for Varipulse PFA
Johnson & Johnson MedTech today announced FDA approval for an update to its Varipulse platform's irrigation flow rate. The company said the update to its pulsed field ablation (PFA) platform reflects its commitment to the evolution of PFA innovation. Its update came on the back of real-world clinical practice. Johnson & Johnson MedTech's … [Read more...] about Johnson & Johnson MedTech gets updated FDA nod for Varipulse PFA
Johnson & Johnson MedTech adds new CMO for its Electrophysiology business
Johnson & Johnson MedTech (NYSE: JNJ) announced that it has a new chief medical & scientific officer for its Electrophysiology unit. Michael Bodner, group chair for Electrophysiology & Neurovascular, posted on LinkedIn that the company appointed Dr. Gregory Michaud to the role. Michaud, a globally recognized electrophysiologist, … [Read more...] about Johnson & Johnson MedTech adds new CMO for its Electrophysiology business
Johnson & Johnson MedTech launches ultrasound catheter for imaging in cardiac ablation procedures
Johnson & Johnson MedTech (NYSE: JNJ) announced today that it launched the SoundStar Crystal ultrasound catheter. The company launched the catheter in the U.S. for intracardiac echocardiography (ICE) imaging in cardiac ablation procedures. SoundStar Crystal provides clearer, enhanced image quality compared to other ICE catheters, according … [Read more...] about Johnson & Johnson MedTech launches ultrasound catheter for imaging in cardiac ablation procedures
J&J’s Shockwave touts study highlighting the use of IVL-first strategy for women
Johnson & Johnson MedTech‘s Shockwave Medical unit today announced study results highlighting the use of its IVL treatment in female patients. Shockwave announced 30-day primary endpoint results from the EMPOWER CAD study of its intravascular lithotripsy (IVL) therapy. It marks the first prospective, real-world percutaneous … [Read more...] about J&J’s Shockwave touts study highlighting the use of IVL-first strategy for women



![The Inlexzo system. [Image courtesy of Johnson & Johnson]](https://www.medicaltubingandextrusion.com/wp-content/uploads/2025/09/Inlexzo-JJ-2-1-300x195.jpg)



